Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Study of Factors Regulating Mast Cell Proliferation Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Study of Factors Regulating Mast Cell Proliferation conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Study of Factors Regulating Mast Cell Proliferation Clinical research trials and Study of Factors Regulating Mast Cell Proliferation medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Study of Factors Regulating Mast Cell Proliferation. Study of Factors Regulating Mast Cell Proliferation Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Study of Factors Regulating Mast Cell Proliferation clinical trial. Subjects often receive the most expert healthcare possible for their Study of Factors Regulating Mast Cell Proliferation condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.

Home > "S" Clinical Trials Conditions > Study of Factors Regulating Mast Cell Proliferation

Study of Factors Regulating Mast Cell Proliferation



Study of Factors Regulating Mast Cell Proliferation

For Condition: Mastocytosis
Status: Recruiting
Sponsor(s): National Institute of Allergy and Infectious Diseases (NIAID) ,
Synopsis: This study will examine growth factors that promote and inhibit mast cell proliferation resulting in mastocytosis, a disease of excessive mast cells in the body. These cells can release chemicals that cause itching, blisters, flushing, bone pain and abdominal pain. Patients up to 80 years of age with mastocytosis may be eligible for this 1-day study. Participants will have one visit at NIH lasting up to 8 hours, during which they will undergo the following tests and procedures: -Medical history and physical examination. -Laboratory studies, if medically indicated. -Blood tests to identify genetic changes important in the growth, development, and functioning of mast cells. -Bone marrow aspiration and biopsy. For the bone marrow procedure, the skin over the hipbone and the outer surface of the bone itself are numbed with local anesthesia. Then, a special needle is inserted into the hipbone and about 1 tablespoon of bone marrow is drawn into a syringe. Another needle is inserted into the same area to collect a small piece of the bone marrow. Additional procedures may include allergen testing, urinalysis, and 24-hour urine collection. Participants will receive an evaluation of their mastocytosis.
Details: This protocol is designed to examine those growth potentiating and inhibiting factors which regulate mast cell number and survival in patients with mastocytosis, and to explore the molecular basis of the disease process in hopes of improving therapy. Patients will carry the diagnosis of mastocytosis based on abnormal bone marrow biopsy and aspirate, abnormal skin biopsy, presence of urticaria pigmentosa, and if available, elevated serum tryptase level greater than 20 ng/ml and the presence of aberrant mast cell morphology and surface markers of CD2 and CD25. Medical work-up is in accordance with standard medical practice. Mastocytosis patients will be children and adults from birth to 80 years of age. The protocol is designated for only one visit. Patients may be asked to re-enter this protocol at a later date for further research or entry into protocol 98-I-0027. This is not a therapeutic protocol and does not involve infusion of any manipulated cells, viruses or DNA constructs into human subjects.
Eligibility:
Study Type:
  Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Birth to 80 years of age. Histiologic evidence of increased mast cell number by bone marrow and/or skin biopsy. Must be under the care of a primary care physician to be enrolled. Patients must be able and willing to undergo a bone marrow biopsy. A bone marrow biopsy will be pre-empted if, during the procedure, the patient experiences significant flushing, pain, hypotension or tachycardia for any reason, which places the patient at risk. EXCLUSION CRITERIA: No histiologic evidence of increased mast cell number by bone marrow and/or skin biopsy. No primary care physician. Anemia with hemoglobin less than 8, hematocrit less than 24. Children weighing more than 4.5 kg will have a maximum of 30 cc blood drawn for studies.
Total Enrollment: 100

Location and Contact Information:

National Institute of Allergy and Infectious Diseases (NIAID) *Recruiting*
Bethesda,  Maryland,  20892
United States
Recruiting Patient  and Public Liaison Office 1-800-411-1222


Additional Information:
Study ID Numbers:
  020277;  02-I-0277
Study Start Date: August 16, 2002
Record last reviewed: June 30, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00044122

Other Mastocytosis Studies:
1. Characteristics of Mast Cells in Mastocytosis

2. Study of Mast Cell Precursors

3. Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing

4. Stem Cell Transplantation to Treat Systemic Mastocytosis

5. Cause and Natural Course of Pediatric-Onset Mastocytosis

Related Studies:

Other Mastocytosis Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials

Study of Factors Regulating Mast Cell Proliferation

Modify your Search

  Other Mastocytosis Clinical Trials
  Other Maryland Clinical Trials
  Other Bethesda Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103